Application of Eudragit RS 30D as a Potential Drug Release Retardant of Acetaminophen and Caffeine for Prolonged Duration of Comfort

Table 3

Evaluation of postcompression parameters of formulation EF1-EF3.

Formulation	Weight variation (mg (±SD)); ()	Hardness (KG (±SD)); ()	Thickness (mm (±SD)); ()	Diameter (mm (±SD)); ()	Friability (%); ()	Assay (%); ()
EF1	1288.05 (±5.698)	7.19 (±0.09)	8.85 (±0.006)	19.41 (±0.01)	0.46	100.43 (±0.756)
EF2	1300.7 (±5.63)	7.29 (±0.055)	8.88 (±0.004)	19.41 (±0.004)	0.46	104.53 (±0.252)
EF3	1350.7 (±3.278)	7.43 (±0.044)	8.89 (±0.007)	19.41 (±0.006)	0.96	98.32 (±0.395)